Deeptech · AI-driven Bioinformatics & Drug Discovery Bengaluru, India
Request a demo
Products

Four products, defined
by what you receive.

Technology explains how OmicsXplore and SilicoXplore work, and Academy explains how to learn them. This page covers what you can commission or license from us.

POWERED BY THE SAME TECHNOLOGIESOMICSXPLORETARGET DISCOVERYSequencing data to ranked targetsSILICOXPLORECANDIDATE DISCOVERYTargets to verified moleculesBOTH TECHNOLOGIESTECHNOLOGY LICENCEYour scientists, our software
The products

Choose by the outcome
you need.

Three are programmes our scientists run for you, and one puts the technologies in your own team’s hands.

Delivered by our team · OmicsXplore

Target Discovery Programme

From sequencing data to a ranked, evidence linked list of targets.

You provide
Sequencing data (FASTQ, BAM or CRAM, or run accessions) and the biological question: a disease, a comparison or a cohort.
You receive
A ranked, evidence linked list of targets, each with its supporting analysis, matched to your question: differential expression, variants, copy number or single cell results.
Scoped per dataset
See the technology
Delivered by our team · SilicoXplore

Candidate Discovery Programme

From a target to a nominated list of candidate molecules.

You provide
A target, as a structure, a sequence or a disease question, and what a good candidate would look like for you.
You receive
A nominated candidate list. Behind it sit target assessment, generative design and machine learning triage, pharmacokinetic and toxicity filtering, docking across up to five engines, and replicate molecular dynamics and binding free energy on the survivors.
Project based, with written milestones. The timeline follows the scope of your question: a focused study moves quickly, a full campaign takes longer
See the technology
Delivered by our team · OmicsXplore and SilicoXplore

End to End Programme

From sequencing reads to a candidate molecule, under one scope.

You provide
Sequencing data and a disease question.
You receive
Target discovery and candidate discovery in one programme, under one scope and one set of milestones, from the first read to the last molecule.
Scoped per programme, with milestones across both stages
See the whole journey
Run by your team · SilicoXplore and OmicsXplore

Technology Licence

The technologies in your team’s hands, on your own targets and data.

You provide
A team, and the targets and data it will work on.
You receive
Access to SilicoXplore, OmicsXplore or both, with onboarding and a named scientific contact, so your team can run the work itself.
Flexible terms, from a few weeks or months to a full year, by seat or by site. Academic rates available. Run it on our secure, high-specification cloud, or deploy it in your own cloud or on your own servers.
Request a demo
Choosing

Which one is for you?

You have sequencing data, but no target.

Target Discovery Programme

You have a target, but no candidate molecules.

Candidate Discovery Programme

You have data and a disease question, and want molecules at the end.

End to End Programme

You have a computational team and want to run the work yourselves.

Technology Licence

Your team needs the skills before the software.

AcademyWorkshops, internships, the Advanced Diploma and research support.

You are not sure yet.

A scoping call

What every delivery contains

The same three things,
every time.

Whichever programme you commission, you receive results you can defend and the record behind them.

01

Ranked results

Targets or candidates in order, each with the evidence behind its position.

02

A written report

Suitable for a grant, a filing or a partner discussion.

03

The parameter trail

Every parameter set, engine version and log behind the work that produced the results.

Proof

Campaigns we have run, and published.

Published campaigns in antimicrobial resistance, tuberculosis and fungal infection, each run end to end on SilicoXplore.

Antimicrobial resistance · NDM-1
752,4364

Generated molecules narrowed to four candidates by a ten-stage cascade, all inside one session.

The full case study
Tuberculosis · MenT3 toxin
100,00014

Around 100,000 de novo molecules shortlisted to fourteen, with the top five checked by molecular dynamics, MM-GBSA and DFT.

Read the paper
Fungal infection · GPI anchored wall transfer protein 1
4

Candidate modulators of a fungal cell wall target, nominated from the same cascade.

Read the paper
Solutions by sector

The same cascade, pointed
at different problems.

The technologies were built for small molecule discovery, but the filters, endpoints and reporting change with the field. These are the sectors we work in today.

Pharmaceutical and biotech

Lead discovery and optimisation against your own targets, with the evidence trail that a partner, a regulator or a diligence process will ask to see.

Academic research groups

Hands-on access to the technologies, with manuscript support when the work is ready to publish.

Contract research organisations

Capacity for computational work delivered under your own reporting, with parameter records your clients can audit.

Agrochemical

Crop protection targets, with property filters and toxicity endpoints tuned to the sector.

Materials and formulation

Crystal structure prediction and solid form work through SilicoCSP, alongside density functional theory for electronic structure.

Public health and neglected disease

Programmes in infectious and neglected disease, as in the campaigns above.

How an engagement works

Five steps, agreed in writing.

No programme starts without a written scope. These steps apply to the three programmes, and a technology licence follows a shorter version of the same path.

01

Scoping call

One conversation about what you have and what you need. No charge and no obligation.

02

Written proposal

Scope, deliverables, milestones, timeline and cost, in writing, before any work begins.

03

Kick off

Targets and data transferred, technology access provisioned, and a named scientific contact assigned to the programme.

04

Milestones

Interim reports at agreed points, so direction can change while there is still budget and time to change it.

05

Delivery and hand over

Everything listed under “What every delivery contains” is handed over together, and your team can open every job record and rerun any step, with or without us.

Before you share anything

Your data and your IP.

The questions a legal or security team will ask, answered before the scoping call rather than after it.

Confidential from the start

Anything you share stays confidential. We are happy to sign a non disclosure agreement before you send us anything sensitive.

The outputs are yours

For the programmes we run, the outputs are yours. Data handling, intellectual property and access controls are set per engagement in the written scope.

Data stays where your policy requires

Where your data sits is part of the same written terms, whichever product you choose.

How deployment works

Start here

Tell us what you are trying to hit.

A scoping call establishes whether there is a problem worth working on together. A computational scientist will discuss how our technologies apply to your programme, which engagement model fits, and whether we are the right partner for the work.